DocMorris AG
ZRSEF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.06 | 0.05 | -0.18 |
| FCF Yield | -21.61% | -15.35% | -58.11% | -8.53% |
| EV / EBITDA | -12.55 | -18.31 | -6.00 | -14.19 |
| Quality | ||||
| ROIC | -14.81% | 11.39% | 4.58% | 10.02% |
| Gross Margin | 21.29% | 20.98% | 17.20% | 15.06% |
| Cash Conversion Ratio | 0.27 | 0.74 | 0.57 | 0.58 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.99% | -17.50% | -14.26% | 8.40% |
| Free Cash Flow Growth | 52.05% | 26.47% | 19.34% | -52.44% |
| Safety | ||||
| Net Debt / EBITDA | -5.76 | -4.94 | -3.60 | -1.39 |
| Interest Coverage | -5.33 | 4.69 | 2.31 | 6.60 |
| Efficiency | ||||
| Inventory Turnover | 21.59 | 14.80 | 16.38 | 15.86 |
| Cash Conversion Cycle | 14.88 | 27.18 | 50.03 | 18.90 |